PDIA3 and neoplasm: Our analysis showed that out of 139 prostate tumor tissues, 65 (46.76%) tissues had high expression of both LEDGF/p75 and ERp57, and 25 (17.98%) tumor tissues had low expression of both proteins (Fig 9C).